Search
for
Sort by
Research 121–150 of 1000+
- Men??s Health
- 5-alpha reductase inhibitors use in prostatic disease and beyond
- 5alpha-reductase: history and clinical importance.
- Dutasteride
- Post-finasteride syndrome: An emerging clinical problem
- Hormesis and medicine
- The Benefits of Dual Inhibition of 5α Reductase
- Estrogen and androgen signaling in the pathogenesis of BPH
- Antioxidant and Antiproliferative Activity of Finasteride against Glioblastoma Cells
- Oral administration of berberine represses macrophage activation-associated benign prostatic hyperplasia: a pivotal involvement of the NF-κB
- Effect of the ethanol extract of Syzygium aromaticum (clove) leaves on the lipid profile and body weight in testosterone-induced benign prostatic hyperplasia rats
- Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride
- Risk of erectile dysfunction associated with use of 5-α reductase inhibitors for benign prostatic hyperplasia or alopecia: population based studies using the Clinical Practice Research Datalink
- Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction
- Intraethnic variation in steroid-5-alpha-reductase polymorphisms in prostate cancer patients: a potential factor implicated in 5-alpha-reductase inhibitor treatment
- What do we know about phytotherapy of benign prostatic hyperplasia?
- Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
- Trends in the Development of New Drugs for Treatment of Benign Prostatic Hyperplasia
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- Androgen Receptor Polymorphism-Dependent Variation in Prostate-Specific Antigen Concentrations of European Men
- Estimating the Contribution of the Prostate to Blood Dihydrotestosterone
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Association Between 5α-Reductase Inhibitors and Prostate Cancer Mortality
- Combined oral contraceptives promote androgen receptor and oestrogen receptor alpha upregulation in the female prostate (Skene’s paraurethral glands) of adult gerbils (Meriones unguiculatus)
- Steroid 5α-reductase inhibition by polymethoxyflavones